TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: The next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-pd-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Brahmer, J. R. AU - Tykodi, S. S. AU - Chow, L. Q. AU - Hwu, W. J. AU - Topalian, S. L. AU - Hwu, P. PY - 2012 DA - 2012// TI - Safety and activity of anti-pd-l1 antibody in patients with advanced cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200694 DO - 10.1056/NEJMoa1200694 ID - Brahmer2012 ER - TY - JOUR AU - Drake, C. G. AU - Jaffee, E. AU - Pardoll, D. M. PY - 2006 DA - 2006// TI - Mechanisms of immune evasion by tumors JO - Adv Immunol VL - 90 UR - https://doi.org/10.1016/S0065-2776(06)90002-9 DO - 10.1016/S0065-2776(06)90002-9 ID - Drake2006 ER - TY - JOUR AU - Pardoll, D. M. PY - 2012 DA - 2012// TI - The blockade of immune checkpoints in cancer immunotherapy JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3239 DO - 10.1038/nrc3239 ID - Pardoll2012 ER - TY - JOUR AU - Zou, W. AU - Chen, L. PY - 2008 DA - 2008// TI - Inhibitory b7-family molecules in the tumour microenvironment JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2326 DO - 10.1038/nri2326 ID - Zou2008 ER - TY - JOUR AU - Thompson, R. H. AU - Dong, H. AU - Lohse, C. M. AU - Leibovich, B. C. AU - Blute, M. L. AU - Cheville, J. C. PY - 2007 DA - 2007// TI - Pd-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2599 DO - 10.1158/1078-0432.CCR-06-2599 ID - Thompson2007 ER - TY - JOUR AU - Gunturi, A. AU - McDermott, D. F. PY - 2014 DA - 2014// TI - Potential of new therapies like anti-pd1 in kidney cancer JO - Curr Treat Options in Oncol VL - 15 UR - https://doi.org/10.1007/s11864-013-0268-y DO - 10.1007/s11864-013-0268-y ID - Gunturi2014 ER - TY - JOUR AU - Delahunt, B. AU - Cheville, J. C. AU - Martignoni, G. AU - Humphrey, P. A. AU - Magi-Galluzzi, C. AU - McKenney, J. PY - 2013 DA - 2013// TI - Members of the ISUP Renal Tumor Panel. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters JO - Am J Surg Pathol VL - 37 UR - https://doi.org/10.1097/PAS.0b013e318299f0fb DO - 10.1097/PAS.0b013e318299f0fb ID - Delahunt2013 ER - TY - JOUR AU - Moch, H. AU - Schraml, P. AU - Bubendorf, L. AU - Mirlacher, M. AU - Kononen, J. AU - Gasser, T. PY - 1999 DA - 1999// TI - High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma JO - Am J Pathol VL - 154 UR - https://doi.org/10.1016/S0002-9440(10)65349-7 DO - 10.1016/S0002-9440(10)65349-7 ID - Moch1999 ER - TY - JOUR AU - Camp, R. L. AU - Charette, L. A. AU - Rimm, D. L. PY - 2000 DA - 2000// TI - Validation of tissue microarray technology in breast carcinoma JO - Lab Invest VL - 80 UR - https://doi.org/10.1038/labinvest.3780204 DO - 10.1038/labinvest.3780204 ID - Camp2000 ER - TY - JOUR AU - Dall'Oglio, M. F. AU - Ribeiro-Filho, L. A. AU - Antunes, A. A. AU - Crippa, A. AU - Nesrallah, L. AU - Gonçalves, P. D. PY - 2007 DA - 2007// TI - Microvascular tumor invasion, tumor size and fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma JO - J Urol VL - 178 UR - https://doi.org/10.1016/j.juro.2007.03.128 DO - 10.1016/j.juro.2007.03.128 ID - Dall'Oglio2007 ER - TY - JOUR AU - Dong, H. AU - Zhu, G. AU - Tamada, K. AU - Chen, L. PY - 1999 DA - 1999// TI - B7-h1, a third member of the b7 family, co-stimulates t-cell proliferation and interleukin-10 secretion JO - Nat Med VL - 5 UR - https://doi.org/10.1038/70932 DO - 10.1038/70932 ID - Dong1999 ER - TY - JOUR AU - Dong, H. AU - Strome, S. E. AU - Salomao, D. R. AU - Tamura, H. AU - Hirano, F. AU - Flies, D. B. PY - 2002 DA - 2002// TI - Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion JO - Nat Med VL - 8 UR - https://doi.org/10.1038/nm0902-1039c DO - 10.1038/nm0902-1039c ID - Dong2002 ER - TY - JOUR AU - Iwai, Y. AU - Ishida, M. AU - Tanaka, Y. AU - Okazaki, T. AU - Honjo, T. AU - Minato, N. PY - 2002 DA - 2002// TI - Involvement of pd-l1 on tumor cells in the escape from host immune system and tumor immunotherapy by pd-l1 blockade JO - Proc Natl Acad Sci U S A VL - 99 UR - https://doi.org/10.1073/pnas.192461099 DO - 10.1073/pnas.192461099 ID - Iwai2002 ER - TY - STD TI - Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, et al. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res. 2006;66:3381–5. ID - ref16 ER - TY - STD TI - Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, et al, et al. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target. Proc Natl Acad Sci U S A. 2004;101:17174–9. ID - ref17 ER - TY - JOUR AU - Choueiri, T. K. AU - Figueroa, D. J. AU - Fay, A. P. AU - Signoretti, S. AU - Liu, Y. AU - Gagnon, R. PY - 2015 DA - 2015// TI - Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial JO - Clin Can Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-1993 DO - 10.1158/1078-0432.CCR-14-1993 ID - Choueiri2015 ER - TY - JOUR AU - Jilaveanu, L. B. AU - Shuch, B. AU - Zito, C. R. AU - Parisi, F. AU - Barr, M. AU - Kluger, Y. PY - 2014 DA - 2014// TI - PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases JO - J Cancer VL - 5 UR - https://doi.org/10.7150/jca.8167 DO - 10.7150/jca.8167 ID - Jilaveanu2014 ER - TY - JOUR AU - Choueiri, T. K. AU - Fay, A. P. AU - Gray, K. P. AU - Callea, M. AU - Ho, T. H. AU - Albiges, L. PY - 2014 DA - 2014// TI - PD-L1 expression in nonclear-cell renal cell carcinoma JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu445 DO - 10.1093/annonc/mdu445 ID - Choueiri2014 ER - TY - JOUR AU - Sabatier, R. AU - Finetti, P. AU - Mamessier, E. AU - Adelaide, J. AU - Chaffanet, M. AU - Ali, H. R. PY - 2015 DA - 2015// TI - Prognostic and predictive value of PDL1 expression in breast cancer JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3216 DO - 10.18632/oncotarget.3216 ID - Sabatier2015 ER - TY - STD TI - Qing Y, Li Q, Ren T, Xia W, Peng Y, Liu GL, et al. Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer. Drug Des Devel Ther. 2015;9:901–9. ID - ref22 ER - TY - JOUR AU - Wang, A. AU - Wang, H. Y. AU - Liu, Y. AU - Zhao, M. C. AU - Zhang, H. J. AU - Lu, Z. Y. PY - 2015 DA - 2015// TI - The prognostic value of PD-L1 expression for non-small cell lung cancer patients: a meta-analysis JO - Eur J Surg Oncol VL - 41 UR - https://doi.org/10.1016/j.ejso.2015.01.020 DO - 10.1016/j.ejso.2015.01.020 ID - Wang2015 ER -